Go back to the main page.
Transforming Today's Science Into Tomorrow's Cures
Samaritan's collaborative researchers have made important patented discoveries in the fields of, central nervous system diseases, such as, Alzheimer's disease; cancer; cardiovascular disease; and infectious diseases, such as, AIDS, and Hepatitis C. These discoveries have positioned us with a rich pipeline of new drugs with novel mechanisms of actions to develop.
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics. At Samaritan Pharmaceuticals our mission has been to create life-saving drugs for people suffering from AIDS, Alzheimer’s, heart disease and cancer. View all the latest press releases and news articles focused on Samaritan Pharmaceuticals, Inc. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Samaritan has collaborative relationships with other pharmaceutical companies to commercialize branded approved prescription products in selected niche territories, such as, in Greece, Albania, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, FYROM, Hungary, Montenegro, Poland, Romania, Serbia, Slovakia, Slovania, Syria and Turkey. Before a drug can be offered to the public it must go through several phases of rigorous testing to make sure it is safe, efficient and does what it says it can do. The testing is mandated and overseen by the U.S. Food and Drug Administration (FDA) which is part of the U.S. Department of Health and Human Services. SAMARITAN PIPELINE - (MECHANISM OF ACTION VIDEOS)
Go back to the main page. Contact Samaritan Pharmaceuticals, Inc. Find what you are looking for in our website.

RESEARCH REPORTS

The following documents are in PDF format. Click on the document title to download the report. To view PDF documents, you will need Adobe® Acrobat® Reader. Download a free copy from the Adobe website.

Analyst Reports


PDF  Taglich Brothers, Inc. Research Report - Update May 07, 2007

PDF  Taglich Brothers, Inc. Research Report - Update Dec. 11, 2006

PDF  Taglich Brothers, Inc. Research Report - Update Sept. 13, 2006

PDF  Taglich Brothers, Inc. Research Report - Update May. 25, 2006

PDF  Reuters Outperform Rating Report - Jan. 20, 2006

PDF  Taglich Brothers, Inc. Research Report Update - Dec. 15, 2005

PDF  Taglich Brothers, Inc. Research Report Update - Sept 26, 2005

PDF  Taglich Brothers, Inc. Research Report Update - June 7, 2005

PDF  Taglich Brothers, Inc. Initial Research Report - May 6, 2005

Industry Reports

PDF  HIV/AIDS Industry Report - April 2005

Partnering
Opportunities